Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 24, 2022
June 24, 2022
0995d9e6-6e6d-4bdf-880c-7d5338ab692d
Related Documents
Psychedelic Drugs: Considerations for Clinical Investigations
Guidance DocumentJune 23, 2023Center for Drug Evaluation and Research
Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework Guidance for Industry
Guidance DocumentJune 20, 2019Center for Drug Evaluation and Research
How To Obtain a Covered Product Authorization
Guidance DocumentSeptember 21, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.